Beta-blockers in cirrhosis: friend and foe?
Wong
Florence
F
Salerno
Francesco
F
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects* / Q000627:therapeutic use*; D004932:Esophageal and Gastric Varices / Q000453:epidemiology / Q000517:prevention & control*; D006801:Humans; D008103:Liver Cirrhosis / Q000150:complications*; D010538:Peritonitis / Q000453:epidemiology; D011433:Propranolol / Q000009:adverse effects / Q000627:therapeutic use; D051437:Renal Insufficiency / Q000453:epidemiology; D012307:Risk Factors
D000319:Adrenergic beta-Antagonists; D011433:Propranolol